These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 8497862)

  • 1. Effects of lipoprotein(a) on in vitro lysis of whole blood thrombi from healthy volunteers.
    Terres W; Krewitt M; Hamm CW
    Thromb Res; 1993 Mar; 69(5):479-87. PubMed ID: 8497862
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Absence of inhibition by lipoprotein (a) inhibition of tPA induced thrombolysis in a patient's plasma milieu.
    Lu H; Bruckert J; Soria J; Li H; de Gennes JL; Legrand A; Peynet J; Soria C
    Blood Coagul Fibrinolysis; 1990 Oct; 1(4-5):513-6. PubMed ID: 1966796
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Does Lp(a) lipoprotein inhibit the fibrinolytic system?
    Halvorsen S; Skjønsberg OH; Berg K; Ruyter R; Godal HC
    Thromb Res; 1992 Nov; 68(3):223-32. PubMed ID: 1471070
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Relationship of lipoprotein(a) to fibrinolytic activities in healthy subjects].
    Xiong X; Zhao S; Wang Z; Lo L; Huang Q
    Hunan Yi Ke Da Xue Xue Bao; 1998; 23(6):555-7. PubMed ID: 10806767
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Euglobulin clot lysis induced by tissue-type plasminogen activator is reduced in subjects with increased levels of lipoprotein (a).
    Aznar J; Estellés A; Bretó M; España F; Alós T
    Thromb Res; 1992 Jun; 66(5):569-82. PubMed ID: 1387993
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Factor XIII and tranexamic acid but not recombinant factor VIIa attenuate tissue plasminogen activator-induced hyperfibrinolysis in human whole blood.
    Dirkmann D; Görlinger K; Gisbertz C; Dusse F; Peters J
    Anesth Analg; 2012 Jun; 114(6):1182-8. PubMed ID: 22104068
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inheritance conjointly contributing to fibrinolysis and hyperlipidemia.
    Glueck CJ; Glueck HI; Tracy T; Speirs J; Stroop D
    Metabolism; 1993 Nov; 42(11):1410-9. PubMed ID: 8231835
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interactions between fibrinolysis, lipoproteins and leptin related to a first myocardial infarction.
    Thøgersen AM; Söderberg S; Jansson JH; Dahlén G; Boman K; Nilsson TK; Lindahl B; Weinehall L; Stenlund H; Lundberg V; Johnson O; Ahrén B; Hallmans G
    Eur J Cardiovasc Prev Rehabil; 2004 Feb; 11(1):33-40. PubMed ID: 15167204
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tissue plasminogen activator and plasminogen activator inhibitor-1 in stroke patients.
    Lindgren A; Lindoff C; Norrving B; Astedt B; Johansson BB
    Stroke; 1996 Jun; 27(6):1066-71. PubMed ID: 8650716
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Potent reduction of plasma lipoprotein (a) with an antisense oligonucleotide in human subjects does not affect ex vivo fibrinolysis.
    Boffa MB; Marar TT; Yeang C; Viney NJ; Xia S; Witztum JL; Koschinsky ML; Tsimikas S
    J Lipid Res; 2019 Dec; 60(12):2082-2089. PubMed ID: 31551368
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effect of chronic allograft rejection on plasma regulators of fibrinolysis.
    Perkowska A; Elhasade A; Durlik M; Placha G; Gałazka Z; Lao M; Gaciong Z
    Ann Transplant; 2002; 7(1):44-51. PubMed ID: 12221903
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Apolipoprotein(a) attenuates endogenous fibrinolysis in the rabbit jugular vein thrombosis model in vivo.
    Biemond BJ; Friederich PW; Koschinsky ML; Levi M; Sangrar W; Xia J; Büller HR; ten Cate JW
    Circulation; 1997 Sep; 96(5):1612-5. PubMed ID: 9315555
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Age dependence of blood fibrinolytic components and the effects of low-dose oral contraceptives on coagulation and fibrinolysis in teenagers.
    Siegbahn A; Ruusuvaara L
    Thromb Haemost; 1988 Dec; 60(3):361-4. PubMed ID: 3149043
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Selected new atherosclerosis risk factors and markers of fibrinolysis in children and adolescents with obesity, hypertension and diabetes].
    Głowińska B; Urban M; Koput A; Galar M
    Przegl Lek; 2003; 60(1):12-7. PubMed ID: 12884639
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Relationships between euglobulin clot lysis time and the plasma levels of tissue plasminogen activator and plasminogen activator inhibitor 1.
    Urano T; Sakakibara K; Rydzewski A; Urano S; Takada Y; Takada A
    Thromb Haemost; 1990 Feb; 63(1):82-6. PubMed ID: 2111051
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Assessment of fibrinolytic activity by measuring the lysis time of a tissue-factor-induced clot: a feasibility evaluation.
    Cellai AP; Lami D; Magi A; Liotta AA; Rogolino A; Antonucci E; Bandinelli B; Abbate R; Prisco D
    Clin Appl Thromb Hemost; 2010 Jun; 16(3):337-44. PubMed ID: 19117964
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Plasma Lp (a) levels and correlation of Lp (a) with fibrinolysis activation in chronic renal failure].
    Zhu J; Xiong X; Zhao S; Wang Z; Lou L; Hang Q
    Hunan Yi Ke Da Xue Xue Bao; 1999; 24(4):366-8. PubMed ID: 12080650
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Plasma lipoprotein(a) levels in subjects attending a metabolic ward. Discrimination between individuals with and without a history of ischemic stroke.
    Margaglione M; DiMinno G; Grandone E; Celentano E; Vecchione G; Cappucci G; Grilli M; Mancini FP; Postiglione A; Panico S; Mancini M
    Arterioscler Thromb Vasc Biol; 1996 Jan; 16(1):120-8. PubMed ID: 8548412
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vitro inhibition of fibrinolysis by apolipoprotein(a) and lipoprotein(a) is size- and concentration-dependent.
    Knapp JP; Herrmann W
    Clin Chem Lab Med; 2004; 42(9):1013-9. PubMed ID: 15497466
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lp(a) is not associated with diabetes but affects fibrinolysis and clot structure ex vivo.
    Månsson M; Kalies I; Bergström G; Schmidt C; Legnehed A; Hultén LM; Amrot-Fors L; Gustafsson D; Knecht W
    Sci Rep; 2014 Jun; 4():5318. PubMed ID: 24937703
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.